- CNR - Centre National De Reference Des Virus De Infections Respiratoires, France, has validated and approved GeneStore RT PCR test for COVID-19
- The test which is 'Made in France', helps deliver results in 1 hour, and is based on a multiplexed one-step RT PCR approach
- GeneStore is commercialising the test at a highly affordable price point of 9,9 Euros, to facilitate higher volumes of testing globally
- The CE-IVD marked test is now being shipped across the European Union, Africa, Latin America and Southeast Asia to expedite availability
- The company can manufacture 1 million test kits per month in France
GEMENOS, France, June 11, 2020 /PRNewswire/ -- GeneStore France SAS, a biotech company, headquartered in Gemenos, France, received approval from CNR France of its Detection Expert SARS-Cov-2 RT-PCR Test for detection of Covid-19 virus.
"The test enables laboratories in going from purified RNA to results in 1 hours time," said Anubhav Anusha, Global CEO of GeneStore.
"In line with our global mission to fight infectious diseases by enabling affordable testing, GeneStore is commercialising the test kit at a highly affordable price of € 9,9, and can manufacture 1 million test kits per month at its France based manufacturing facility," added Anubhav.
About the Detection Expert 1S SARS-Cov-2 RT PCR one step kit:
- The test identifies 2 target regions within the 'N' gene of the SARS-Cov2 RNA genome in a multiplex format, along with a separate reaction for the internal control.
- A positive control formed with non-pathogen fragments of SARS-Cov2 viral genome is also provided.
- PCR cycling is fast (just 60-68 minutes).
- It is compatible with most real-time PCR machines with at least 2-channels for signal detection.
- The kit is sensitive, detecting low virus loads in the upper respiratory tract biosamples.
- Clinical validation of its performances were performed across multiple centers in France, Spain, and India with success.
About GeneStore France:
GeneStore France is part of the International GeneStore Global consortium composed of ISO13485 / ISO15189 facilities across the world, which has screened genomes of over half a million individuals globally. GeneStore also develops and delivers custom A.I. enabled genomics and proteomics based solutions to institutional clients across the pharmaceutical, healthcare and dermocosmetic industries. The company has committed itself to the task of developing and delivering cost-effective molecular diagnostic solutions for infectious diseases at a global scale.
For further information, visit: www.genestore.org or email: adriana.lopez.es@genestore.org.
Logo: https://mma.prnewswire.com/media/1178925/GeneStore_Logo.jpg
